Edition:
United States

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Capital Market

17.30USD
14 Dec 2017
Change (% chg)

$0.40 (+2.37%)
Prev Close
$16.90
Open
$17.05
Day's High
$17.65
Day's Low
$16.70
Volume
85,808
Avg. Vol
175,641
52-wk High
$19.10
52-wk Low
$2.70

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Rodney Lappe

61 2016 Executive Chairman of the Board

Charles Baum

59 2012 President, Chief Executive Officer, Director

Jamie Donadio

41 2016 Chief Financial Officer, Senior Vice President

Isan Chen

52 2013 Chief Medical and Development Officer, Executive Vice President

Christopher LeMasters

2016 Executive Vice President, Chief Business Officer